SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses potential bullish setups, including golden cross formations and historical support levels. Some believe LTC is poised for a significant run, while others highlight its potential against Bitcoin and Ethereum. Discussions also involve potential price targets and the impact of broader market trends on Litecoin's performance.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

Treasure Global (TGL) is trending due to a surge in after-hours trading, driven by positive profit outlook news, sparking comparisons to previous runners like $SMX. The community is actively discussing price targets and the potential for a short squeeze, fueled by a low float and high short interest. Some traders believe TGL could reach new highs, while others caution about the risks associated with reverse splits and potential dilution.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Recent news of Netflix potentially acquiring Warner Bros. is driving significant conversation around $NFLX. The community is discussing the potential impact of this deal, including concerns about market share and regulatory hurdles, while some see it as a strategic move for content dominance and long-term growth. Community members are actively speculating on the deal's likelihood and its potential effects on the streaming landscape.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its strong community and meme-driven culture, with community members actively spreading awareness of the "infection". The coin, originating from $PUMP on the Solana chain, emphasizes fun and energy, attracting attention from those seeking engaging meme-based investments. The community is celebrating its organic growth and the "virus" spreading across multiple platforms, expressing confidence for the future.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending as traders discuss its potential for a significant squeeze, drawing comparisons to recent runners like $SMX and $TGL. Community members are focused on the stock's low float and a reported FY25 profit outlook as potential catalysts. Some traders caution about risks associated with Hong Kong-based companies and potential dilutions.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending due to positive community sentiment surrounding their ASH oral data and a subsequent upsized $100M offering, interpreted as a strong institutional buy signal.  The community is focused on the implications of the upsized offering after the data release, suggesting confidence in the company's prospects. Discussions revolve around the potential for an accelerated BLA submission and future buyout opportunities.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

MTVA is trending due to community discussion around its low float and potential for significant price movement, with traders actively monitoring overnight action and anticipating a continued run. Some investors are optimistic about potential catalysts and the company's pipeline, while others express caution regarding dilution and the company's financials, contributing to the stock's volatile trading pattern.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic ($LUNC) is trending amid community excitement and volatility, with some traders eyeing potential run-ups while others remain cautious due to its history. Key talking points include potential Binance upgrades, Do Kwon's legal situation, and the impact of token burns on reducing supply. Despite differing opinions, community members express hope for a significant comeback, drawing attention to increased trading volume and potential for both gains and losses.

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

FULC is trending due to positive data from its PIONEER trial for sickle cell disease, presented at the American Society of Hematology meeting. Community discussions highlight the potential for a functional cure and a direct move toward registration trials. Investors are also optimistic about the global sickle cell disease treatment market and FULC's potential leadership in oral therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assertio (NASDAQ:ASRT) Rating Increased to Buy at Wall Street Zen

Wall Street Zen raised Assertio to a "buy" rating in a research note on Saturday...

Assertio (NASDAQ:ASRT) Issues Quarterly Earnings Results, Beats Expectations By $0.19 EPS

Assertio (NASDAQ:ASRT - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of...

Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of +237.50% and +83.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Assertio Reports Third Quarter 2025 Financial Results

Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients...

Earnings Outlook For Assertio Holdings

Xeris Biopharma (XERS) Reports Break-Even Earnings for Q3

Xeris Biopharma (XERS) delivered earnings and revenue surprises of -100.00% and +0.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for September 23rd

ATS, ASRT and DBVT have been added to the Zacks Rank #5 (Strong Sell) List on September 23, 2025.

New Strong Sell Stocks for September 19th

ASRT, CE and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 19, 2025.

New Strong Sell Stocks for September 16th

ASRT, ARMN and AMRZ have been added to the Zacks Rank #5 (Strong Sell) List on September 16, 2025.

New Strong Sell Stocks for August 26th

ASRT, BSM and JJSF have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2025.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.21	--	--	N/A
Q3 '25	-$0.09	$0.11	229.41%	BEAT
Q2 '25	-$0.09	-$0.17	-88.89%	MISSED
Q1 '25	-$0.06	-$0.14	-133.33%	MISSED
Q4 '24	-$0.04	-$0.11	-150.00%	MISSED

ASRT
Assertio Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest ASRT News

ASRTAssertio Holdings Inc